Delirium: draft scope comments proforma Delirium: draft scope comments proforma 16 April 2008 (47.5 Kb 13 sec) Word Viewer may be required. This page was last updated: 30 March 2010 Stakeholder list PDF 119 KB 31 October 2018 Surveillance review proposal PDF 1.01 MB 31 August 2018 Comments form MSWord 28 KB 31 August 2018 Stakeholder list - review proposal PDF 191 KB 30 October 2014 Review proposal PDF 471 KB 30 October 2014 Surveillance review decision PDF 699 KB 28 January 2015 Evidence update PDF 350 KB 01 April 2012 2010/103 New NICE guideline set to encourage healthcare professionals to 'think delirium' and take steps to prevent it PDF 166 KB 06 December 2013 Remit PDF 14 KB 31 October 2007 List of stakeholders PDF 23 KB 12 July 2010 Final scope PDF 111 KB 03 July 2008 Stakeholder comments on draft scope PDF 199 KB 12 August 2008 Draft scope for consultation PDF 119 KB 16 April 2008 Draft scope comments proforma MSWord 48 KB 16 April 2008 List of stakeholders PDF 23 KB 12 July 2010 Equalities impact assessment (recommendations) PDF 29 KB 28 July 2010 GDG membership list PDF 19 KB 03 July 2008 Delirium GDG minutes: 16 July 2009 PDF 35 KB 20 October 2009 Delirium GDG minutes: 15 July 2009 PDF 35 KB 20 October 2009 Delirium GDG minutes: 22 April 2009 PDF 34 KB 20 October 2009 Delirium GDG minutes: 3-4 July 2008 PDF 38 KB 22 October 2008 Delirium GDG minutes: 13 November 2008 PDF 19 KB 17 March 2009 Delirium GDG minutes: 21-22 January 2009 PDF 20 KB 22 April 2009 Delirium GDG minutes: 4 March 2009 PDF 87 KB 30 July 2009 Draft full guideline for consultation PDF 1.85 MB 11 November 2009 Algorithm PDF 45 KB 11 November 2009 Appendices and contents page PDF 615 KB 11 November 2009 Appendix D adverse effects - included studies PDF 233 KB 11 November 2009 Appendix D consequences of - included studies PDF 155 KB 11 November 2009 Appendix D diagnostic test accuracy - included studies PDF 182 KB 11 November 2009 Appendix D epidemiology - included studies PDF 214 KB 11 November 2009 Appendix D non pharmacological risk factors - included studies PDF 90 KB 11 November 2009 Appendix D pharmacological risk factors - included studies PDF 49 KB 11 November 2009 Appendix E consequences of cohort studies - methodological quality PDF 125 KB 11 November 2009 Appendix E diagnostic accuracy tests - methodological quality PDF 172 KB 11 November 2009 Appendix E epidemiology - methodological quality PDF 168 KB 11 November 2009 Appendix E non-pharmacological risk factors cohort studies - methodological quality PDF 44 KB 11 November 2009 Appendix E pharmacological risk factors cohort studies - methodological quality PDF 29 KB 11 November 2009 Appendix E patient information - methodological quality PDF 213 KB 11 November 2009 Appendix F consequences of - multivariate risk factors PDF 185 KB 11 November 2009 Appendix F - non-pharmacological risk factors - multivariate risk factors PDF 293 KB 11 November 2009 Appendix F pharmacological risk factors - multivariate risk factors PDF 63 KB 11 November 2009 Appendix G diagnostic test accuracy - excluded studies PDF 128 KB 11 November 2009 Appendix G adverse effects review - excluded studies PDF 121 KB 11 November 2009 Appendix G consequences of - excluded studies PDF 55 KB 11 November 2009 Appendix G epidemiology review - excluded studies PDF 146 KB 11 November 2009 Appendix G non-pharmacological risk factors - excluded studies PDF 71 KB 11 November 2009 Appendix G information for patients review - excluded studies PDF 118 KB 11 November 2009 Appendix G pharmacological risk factors - excluded studies PDF 55 KB 11 November 2009 Appendix G references to excluded studies PDF 151 KB 11 November 2009 Appendix K evidence summary - prevention PDF 34 KB 11 November 2009 Appendix K evidence summary - treatment PDF 39 KB 11 November 2009 Draft NICE guideline for consultation PDF 250 KB 11 November 2009 Consultation table and with developers responses PDF 1.02 MB 07 May 2010 Pre-publication check - stakeholder comments/developer responses PDF 49 KB 28 July 2010 Full guideline PDF 3.5 MB 07 May 2010 Appendix A - Scope PDF 64 KB 07 May 2010 Appendix B - Declaration of Interests PDF 49 KB 07 May 2010 Appendix C - Search Strategies PDF 174 KB 07 May 2010 Appendix D - Adverse Effects - Included studies PDF 121 KB 07 May 2010 Appendix D - Consequences of - Included studies PDF 155 KB 07 May 2010 Appendix D - Diagnostic Test Accuracy - Included Studies PDF 182 KB 07 May 2010 Appendix D - Epidemiology - Included studies PDF 91 KB 07 May 2010 Appendix D - Non pharmacological Risk factor - Included studies PDF 44 KB 07 May 2010 Appendix D - Pharma Nonpharma Prevention Treatment - Included studies PDF 170 KB 07 May 2010 Appendix D - Pharmacological Risk factors - Included studies PDF 49 KB 07 May 2010 Appendix E - Consequences of PDF 125 KB 07 May 2010 Appendix E - Diagnostic Accuracy Tests Methodological Quality PDF 172 KB 07 May 2010 Appendix E - Epidemiology quality PDF 71 KB 07 May 2010 Appendix E - Non Pharmacological Risk Factors PDF 44 KB 07 May 2010 Appendix E - Patient info quality PDF 80 KB 07 May 2010 Appendix E - Pharma NonPharma Prevention Treatment PDF 107 KB 07 May 2010 Appendix E - Pharmacological Risk Factors review - Randomised controlled trials PDF 23 KB 07 May 2010 Appendix E - Pharmacological Risk Factors review - cohort studies PDF 30 KB 07 May 2010 Appendix G - References for Excluded Studies PDF 93 KB 07 May 2010 Appendix H - Recommendations for Future Research PDF 75 KB 07 May 2010 Appendix I - DSM-IV and Scales For Measuring PDF 64 KB 07 May 2010 Appendix J - Health Economics PDF 155 KB 07 May 2010 Appendix K - Forest Plots PDF 462 KB 07 May 2010 Consultation table and with developers responses PDF 1.02 MB 07 May 2010
